237 related articles for article (PubMed ID: 16829119)
21. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
22. Novel investigational drugs for gastric cancer.
Vecchione L; Orditura M; Ciardiello F; De Vita F
Expert Opin Investig Drugs; 2009 Jul; 18(7):945-55. PubMed ID: 19466878
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapy: novel agents against cancer.
Tongyoo A
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S311-23. PubMed ID: 21294432
[TBL] [Abstract][Full Text] [Related]
24. Systemic treatment of gastric cancer.
Morabito A; Carillio G; Longo R
Crit Rev Oncol Hematol; 2009 Jun; 70(3):216-34. PubMed ID: 18829344
[TBL] [Abstract][Full Text] [Related]
25. Molecularly targeted therapies in advanced gastric cancer.
Janjigian YY; Shah MA
Minerva Gastroenterol Dietol; 2011 Mar; 57(1):75-88. PubMed ID: 21372772
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies.
Patel JD
Curr Opin Oncol; 2006 Nov; 18(6):609-14. PubMed ID: 16988582
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in the nonsurgical treatment of upper gastrointestinal tract tumors.
Thomas AL; Steward WP
Expert Rev Anticancer Ther; 2001 Aug; 1(2):258-68. PubMed ID: 12113031
[TBL] [Abstract][Full Text] [Related]
28. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
29. Small molecule inhibitors in children with malignant gliomas.
Herrington B; Kieran MW
Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
[TBL] [Abstract][Full Text] [Related]
30. Integrating new targeted agents into the treatment of non-small-cell lung cancer.
Thatcher N
Lung Cancer; 2006 Dec; 54 Suppl 2():S25-31. PubMed ID: 17056150
[TBL] [Abstract][Full Text] [Related]
31. The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer.
Hong L; Han Y; Brain L
Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):111-7. PubMed ID: 24410474
[TBL] [Abstract][Full Text] [Related]
32. Small molecule signal transduction inhibitors for the treatment of solid tumors.
Leary A; Johnston SR
Cancer Invest; 2007 Aug; 25(5):347-65. PubMed ID: 17661211
[TBL] [Abstract][Full Text] [Related]
33. Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancers.
Capdevila J; Ramos FJ; Macarulla T; Elez E; Ruiz-Echarri M; Perez-Garcia J; Tabernero J
Curr Opin Oncol; 2009 Jul; 21(4):374-80. PubMed ID: 19412097
[TBL] [Abstract][Full Text] [Related]
34. Novel therapeutics in colorectal cancer.
McWilliams RR; Erlichman C
Dis Colon Rectum; 2005 Aug; 48(8):1632-50. PubMed ID: 15906130
[TBL] [Abstract][Full Text] [Related]
35. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
[TBL] [Abstract][Full Text] [Related]
36. Molecular targets of selenium in prostate cancer prevention (Review).
Abdulah R; Kobayashi K; Yamazaki C; Koyama H
Int J Oncol; 2011 Aug; 39(2):301-9. PubMed ID: 21567081
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
38. Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.
Sangha R; Lara PN; Mack PC; Gandara DR
Curr Opin Oncol; 2009 Mar; 21(2):116-23. PubMed ID: 19532012
[TBL] [Abstract][Full Text] [Related]
39. Targeting signal transduction pathways in colorectal cancer--more than skin deep.
Cohen SJ; Cohen RB; Meropol NJ
J Clin Oncol; 2005 Aug; 23(23):5374-85. PubMed ID: 15998904
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor: an important target in esophageal cancer.
Hong L; Han Y; Brain L
Expert Opin Ther Targets; 2013 Oct; 17(10):1179-85. PubMed ID: 23855932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
